As of 2024-12-11, the Intrinsic Value of Aptose Biosciences Inc (APS.TO) is
-20.48 CAD. This APS.TO valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.29 CAD, the upside of Aptose Biosciences Inc is
-7,160.69%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-20.48 CAD
Intrinsic Value
APS.TO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-20.48 - -20.48 |
-20.48 |
-7,160.69% |
| P/E |
(17.46) - (4.68) |
(12.87) |
-4536.6% |
| DDM - Stable |
(11.52) - (40.68) |
(26.10) |
-9100.3% |
| DDM - Multi |
(9.91) - (29.98) |
(15.22) |
-5347.5% |
APS.TO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
7.94 |
| Beta |
-0.49 |
| Outstanding shares (mil) |
27.38 |
| Enterprise Value (mil) |
-2.46 |
| Market risk premium |
5.10% |
| Cost of Equity |
13.73% |
| Cost of Debt |
5.00% |
| WACC |
8.71% |